Related Experiment Video
Updated: Jul 1, 2025
04:38
Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
300
Long-term outcome of uniport vs. multiport video-assisted thoracoscopic lobectomy for lung cancer
Yingding Ruan1, Wenjun Cao2, Hongsheng Xue2
1Department of Thoracic Surgery, The First People's Hospital of Jiande, JianDe, 311699, China.
Scientific Reports
|March 4, 2024
Summary
Single-port video-assisted thoracoscopic surgery (U-VATS) lobectomy shows similar perioperative outcomes and long-term survival compared to multiportal VATS (M-VATS) for non-small cell lung cancer (NSCLC). This minimally invasive approach offers comparable efficacy and safety.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Minimally Invasive Procedures
Background:
- Video-assisted thoracoscopic surgery (VATS) lobectomy is a standard treatment for early-stage non-small cell lung cancer (NSCLC).
- Single-port VATS (U-VATS) has emerged as a less invasive alternative to multiportal VATS (M-VATS).
- Direct comparative data on perioperative and long-term outcomes between U-VATS and M-VATS for NSCLC are limited.
Purpose of the Study:
- To compare the perioperative outcomes and long-term survival between U-VATS lobectomy and M-VATS lobectomy for NSCLC.
- To evaluate the safety and efficacy of U-VATS in the context of lung cancer surgery.
- To identify potential differences in patient recovery and survival based on the number of ports used in VATS lobectomy.
Main Methods:
- Retrospective analysis of 339 patients undergoing VATS lobectomy for lung cancer between 2012 and 2017.
- Propensity score matching was used to create comparable cohorts of U-VATS and M-VATS patients.
- Evaluation of perioperative outcomes (e.g., bleeding, hospital stay, morbidity) and long-term survival (overall survival and disease-free survival).
Main Results:
- Conversion rates to open thoracotomy were similar between U-VATS (4.96%) and M-VATS (5.05%).
- After propensity matching (106 pairs), intraoperative bleeding, lymph node retrieval, drainage parameters, and postoperative hospital stay were comparable.
- Morbidity, mortality, overall survival, and disease-free survival showed no significant differences between the U-VATS and M-VATS groups.
Conclusions:
- Single-port VATS lobectomy provides comparable perioperative outcomes to multiportal VATS lobectomy for NSCLC.
- Long-term survival, including overall and disease-free survival, is similar between U-VATS and M-VATS approaches.
- U-VATS is a safe and effective minimally invasive option for NSCLC, though further research is warranted for confirmation.
